Somatostatin was first discovered in hypothalamic
extracts and identified as a hormone that
inhibited secretion of growth hormone. Subsequently,
somatostatin was found to be secreted by a
broad range of tissues, including pancreas,
intestinal tract and regions of the central
nervous system outside the hypothalamus.
Five stomatostatin receptors have been identified
and characterized, all of which are members
of the G protein-coupled receptor superfamily.
Each of the receptors activates distinct signalling
mechanisms within cells, although all inhibit
adenylyl cyclase.
Lipotec produces Somatostatin Acetate Pheur
by the Solid Phase Peptide synthesis method.
Check the available documents at the end of
this page for more information about it.
BCN Peptides holds a Certificate of Suitability
of the European Pharmacopoeia for this product..